Uniphar company profile
Company profile
Uniphar has 3,500 employees and is headquartered in Dublin, Ireland.
With revenue of EUR 3.1 billion in its latest fiscal year, Uniphar plc runs a healthcare services business spanning three divisions: Uniphar Medtech, Uniphar Pharma and Uniphar Supply Chain & Retail. Uniphar Medtech handles sales, marketing, servicing, quality and regulatory support for medical device makers, while Uniphar Pharma offers services across the life cycle of medicines, including access to products that are hard to source through conventional channels. The group also wholesales pharmaceuticals, healthcare goods and animal health products to pharmacies, hospitals and veterinary practices, and operates a pharmacy network under the Life, Allcare, Hickey's and McCauley names. Its customers include manufacturers, healthcare professionals and retail pharmacies, and its activities are carried out in Ireland, the United Kingdom, the Netherlands and other markets abroad.
In the fiscal year ended December 2025, revenue rose 11.0% to EUR 3.1 billion and net profit reached EUR 51.1 million. The group employs 3,500 people and is headquartered in Dublin, where it was founded in 1967.
Company facts
- Sector
- Industrials
- Industry
- Medical Distribution
- Country
- Ireland
- Headquarters
- 4045 Kingswood Road, D24 V06K, Dublin
- Employees
- 3,500
- Chief executive
- Gerard Rabbette
- Founded
- 1967
- Fiscal year
- January - December
- Listing
- UPR · Euronext Dublin
- Currency
- EUR
- ISIN
- IE00BJ5FQX74
- Website
- uniphar.ie
Uniphar and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| UnipharUPR | Ireland | $1.25B | 3,500 | 2.9% | 20.8 |
| NEUCANEU | Poland | $801.3M | 5,004 | 2.0% | 16.7 |
| Asker Healthcare GroupASKER | Sweden | $2.82B | 4,898 | 6.7% | 37.8 |
| AmplifonAMP | Italy | $3.81B | 11,792 | 10.3% | 35.7 |
| GalenicaGALE | Switzerland | $5.42B | 6,623 | 4.8% | 28.3 |
| Sinopharm Group Ltd H1099 | Hong Kong SAR China | $6.68B | 94,910 | 3.0% | 6.51 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
